 | • レポートコード：MRC2102QY0807 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：材料、化学 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のAPI（医薬品有効成分）中間体市場について種類別（製品、中間体）、用途別（腫瘍、糖尿病、内分泌学、心血管疾患、CNS＆神経障害）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・API（医薬品有効成分）中間体市場の概要 ・世界の主要地域別API（医薬品有効成分）中間体市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のAPI（医薬品有効成分）中間体市場規模2015-2026：種類別（製品、中間体） ・世界のAPI（医薬品有効成分）中間体市場規模2015-2026：用途別（腫瘍、糖尿病、内分泌学、心血管疾患、CNS＆神経障害） ・API（医薬品有効成分）中間体の米国市場規模2015-2020 ・API（医薬品有効成分）中間体のヨーロッパ市場規模2015-2020 ・API（医薬品有効成分）中間体の中国市場規模2015-2020 ・API（医薬品有効成分）中間体の日本市場規模2015-2020 ・API（医薬品有効成分）中間体の東南アジア市場規模2015-2020 ・API（医薬品有効成分）中間体のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・API（医薬品有効成分）中間体の製造コスト分析 ・販売チャネル、流通業者、顧客 ・API（医薬品有効成分）中間体の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global API(Active Pharmaceutical Ingredient) Intermediate Market
The global API(Active Pharmaceutical Ingredient) Intermediate market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global API(Active Pharmaceutical Ingredient) Intermediate Scope and Market Size
The global API(Active Pharmaceutical Ingredient) Intermediate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global API(Active Pharmaceutical Ingredient) Intermediate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the API(Active Pharmaceutical Ingredient) Intermediate market is segmented into
By Product
By Type of Intermediate
Segment by Application, the API(Active Pharmaceutical Ingredient) Intermediate market is segmented into
Oncology
Diabetes
Endocrinology
Cardiovascular Disease
CNS & Neurological Disorders
The API(Active Pharmaceutical Ingredient) Intermediate market is analysed and market size information is provided by regions (countries). Segment by Application, the API(Active Pharmaceutical Ingredient) Intermediate market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and API(Active Pharmaceutical Ingredient) Intermediate Market Share Analysis
API(Active Pharmaceutical Ingredient) Intermediate market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in API(Active Pharmaceutical Ingredient) Intermediate business, the date to enter into the API(Active Pharmaceutical Ingredient) Intermediate market, API(Active Pharmaceutical Ingredient) Intermediate product introduction, recent developments, etc.
The major vendors covered:
Jigs Chemical
Sanofi Winthrop Industrie S.A.
Shandong Jiulong Fine Chemical Co., Ltd.
Hipharma Limited
AMPAC Fine Chemicals
BASF
Cambrex Corporation
A R Life Sciences Pvt. Ltd.
Dragon Hwa ChemPharm. Co., Ltd.
Ami Life Sciences Pvt. Ltd.
1 API(Active Pharmaceutical Ingredient) Intermediate Market Overview
1.1 API(Active Pharmaceutical Ingredient) Intermediate Product Scope
1.2 API(Active Pharmaceutical Ingredient) Intermediate Segment by Type
1.2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales by Type (2020-2026)
1.2.2
1.2.3
1.3 API(Active Pharmaceutical Ingredient) Intermediate Segment by Application
1.3.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Comparison by Application (2020-2026)
1.3.2 Oncology
1.3.3 Diabetes
1.3.4 Endocrinology
1.3.5 Cardiovascular Disease
1.3.6 CNS & Neurological Disorders
1.4 API(Active Pharmaceutical Ingredient) Intermediate Market Estimates and Forecasts (2015-2026)
1.4.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2026)
1.4.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate (2015-2026)
1.4.3 Global API(Active Pharmaceutical Ingredient) Intermediate Price Trends (2015-2026)
2 API(Active Pharmaceutical Ingredient) Intermediate Estimate and Forecast by Region
2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global API(Active Pharmaceutical Ingredient) Intermediate Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Region (2015-2020)
2.2.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Region (2015-2020)
2.3 Global API(Active Pharmaceutical Ingredient) Intermediate Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States API(Active Pharmaceutical Ingredient) Intermediate Estimates and Projections (2015-2026)
2.4.2 Europe API(Active Pharmaceutical Ingredient) Intermediate Estimates and Projections (2015-2026)
2.4.3 China API(Active Pharmaceutical Ingredient) Intermediate Estimates and Projections (2015-2026)
2.4.4 Japan API(Active Pharmaceutical Ingredient) Intermediate Estimates and Projections (2015-2026)
2.4.5 Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Estimates and Projections (2015-2026)
2.4.6 India API(Active Pharmaceutical Ingredient) Intermediate Estimates and Projections (2015-2026)
3 Global API(Active Pharmaceutical Ingredient) Intermediate Competition Landscape by Players
3.1 Global Top API(Active Pharmaceutical Ingredient) Intermediate Players by Sales (2015-2020)
3.2 Global Top API(Active Pharmaceutical Ingredient) Intermediate Players by Revenue (2015-2020)
3.3 Global API(Active Pharmaceutical Ingredient) Intermediate Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in API(Active Pharmaceutical Ingredient) Intermediate as of 2019)
3.4 Global API(Active Pharmaceutical Ingredient) Intermediate Average Price by Company (2015-2020)
3.5 Manufacturers API(Active Pharmaceutical Ingredient) Intermediate Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key API(Active Pharmaceutical Ingredient) Intermediate Players (Opinion Leaders)
4 Global API(Active Pharmaceutical Ingredient) Intermediate Market Size by Type
4.1 Global API(Active Pharmaceutical Ingredient) Intermediate Historic Market Review by Type (2015-2020)
4.1.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type (2015-2020)
4.1.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Type (2015-2020)
4.1.3 Global API(Active Pharmaceutical Ingredient) Intermediate Price by Type (2015-2020)
4.2 Global API(Active Pharmaceutical Ingredient) Intermediate Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Forecast by Type (2021-2026)
4.2.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast by Type (2021-2026)
4.2.3 Global API(Active Pharmaceutical Ingredient) Intermediate Price Forecast by Type (2021-2026)
5 Global API(Active Pharmaceutical Ingredient) Intermediate Market Size by Application
5.1 Global API(Active Pharmaceutical Ingredient) Intermediate Historic Market Review by Application (2015-2020)
5.1.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application (2015-2020)
5.1.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Application (2015-2020)
5.1.3 Global API(Active Pharmaceutical Ingredient) Intermediate Price by Application (2015-2020)
5.2 Global API(Active Pharmaceutical Ingredient) Intermediate Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Forecast by Application (2021-2026)
5.2.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast by Application (2021-2026)
5.2.3 Global API(Active Pharmaceutical Ingredient) Intermediate Price Forecast by Application (2021-2026)
6 United States API(Active Pharmaceutical Ingredient) Intermediate Market Facts & Figures
6.1 United States API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Company (2015-2020)
6.2 United States API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type (2015-2020)
6.3 United States API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application (2015-2020)
7 Europe API(Active Pharmaceutical Ingredient) Intermediate Market Facts & Figures
7.1 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Company (2015-2020)
7.2 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type (2015-2020)
7.3 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application (2015-2020)
8 China API(Active Pharmaceutical Ingredient) Intermediate Market Facts & Figures
8.1 China API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Company (2015-2020)
8.2 China API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type (2015-2020)
8.3 China API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application (2015-2020)
9 Japan API(Active Pharmaceutical Ingredient) Intermediate Market Facts & Figures
9.1 Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Company (3015-3030)
9.2 Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type (2015-2020)
9.3 Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application (2015-2020)
10 Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Market Facts & Figures
10.1 Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Company (2015-2020)
10.2 Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type (2015-2020)
10.3 Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application (2015-2020)
11 India API(Active Pharmaceutical Ingredient) Intermediate Market Facts & Figures
11.1 India API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Company (2015-2020)
11.2 India API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type (2015-2020)
11.3 India API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in API(Active Pharmaceutical Ingredient) Intermediate Business
12.1 Jigs Chemical
12.1.1 Jigs Chemical Corporation Information
12.1.2 Jigs Chemical Business Overview
12.1.3 Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Products Offered
12.1.5 Jigs Chemical Recent Development
12.2 Sanofi Winthrop Industrie S.A.
12.2.1 Sanofi Winthrop Industrie S.A. Corporation Information
12.2.2 Sanofi Winthrop Industrie S.A. Business Overview
12.2.3 Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Products Offered
12.2.5 Sanofi Winthrop Industrie S.A. Recent Development
12.3 Shandong Jiulong Fine Chemical Co., Ltd.
12.3.1 Shandong Jiulong Fine Chemical Co., Ltd. Corporation Information
12.3.2 Shandong Jiulong Fine Chemical Co., Ltd. Business Overview
12.3.3 Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Products Offered
12.3.5 Shandong Jiulong Fine Chemical Co., Ltd. Recent Development
12.4 Hipharma Limited
12.4.1 Hipharma Limited Corporation Information
12.4.2 Hipharma Limited Business Overview
12.4.3 Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Products Offered
12.4.5 Hipharma Limited Recent Development
12.5 AMPAC Fine Chemicals
12.5.1 AMPAC Fine Chemicals Corporation Information
12.5.2 AMPAC Fine Chemicals Business Overview
12.5.3 AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Gross Margin (2015-2020)
12.5.4 AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Products Offered
12.5.5 AMPAC Fine Chemicals Recent Development
12.6 BASF
12.6.1 BASF Corporation Information
12.6.2 BASF Business Overview
12.6.3 BASF API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Gross Margin (2015-2020)
12.6.4 BASF API(Active Pharmaceutical Ingredient) Intermediate Products Offered
12.6.5 BASF Recent Development
12.7 Cambrex Corporation
12.7.1 Cambrex Corporation Corporation Information
12.7.2 Cambrex Corporation Business Overview
12.7.3 Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Products Offered
12.7.5 Cambrex Corporation Recent Development
12.8 A R Life Sciences Pvt. Ltd.
12.8.1 A R Life Sciences Pvt. Ltd. Corporation Information
12.8.2 A R Life Sciences Pvt. Ltd. Business Overview
12.8.3 A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Gross Margin (2015-2020)
12.8.4 A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Products Offered
12.8.5 A R Life Sciences Pvt. Ltd. Recent Development
12.9 Dragon Hwa ChemPharm. Co., Ltd.
12.9.1 Dragon Hwa ChemPharm. Co., Ltd. Corporation Information
12.9.2 Dragon Hwa ChemPharm. Co., Ltd. Business Overview
12.9.3 Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Products Offered
12.9.5 Dragon Hwa ChemPharm. Co., Ltd. Recent Development
12.10 Ami Life Sciences Pvt. Ltd.
12.10.1 Ami Life Sciences Pvt. Ltd. Corporation Information
12.10.2 Ami Life Sciences Pvt. Ltd. Business Overview
12.10.3 Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Products Offered
12.10.5 Ami Life Sciences Pvt. Ltd. Recent Development
13 API(Active Pharmaceutical Ingredient) Intermediate Manufacturing Cost Analysis
13.1 API(Active Pharmaceutical Ingredient) Intermediate Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of API(Active Pharmaceutical Ingredient) Intermediate
13.4 API(Active Pharmaceutical Ingredient) Intermediate Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 API(Active Pharmaceutical Ingredient) Intermediate Distributors List
14.3 API(Active Pharmaceutical Ingredient) Intermediate Customers
15 Market Dynamics
15.1 API(Active Pharmaceutical Ingredient) Intermediate Market Trends
15.2 API(Active Pharmaceutical Ingredient) Intermediate Opportunities and Drivers
15.3 API(Active Pharmaceutical Ingredient) Intermediate Market Challenges
15.4 API(Active Pharmaceutical Ingredient) Intermediate Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market API(Active Pharmaceutical Ingredient) Intermediate Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Region (2015-2020)
Table 5. Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Region (2015-2020)
Table 6. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Region (2015-2020)
Table 8. Global API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share Forecast by Region (2021-2026)
Table 10. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share Forecast by Region (2021-2026)
Table 12. Global API(Active Pharmaceutical Ingredient) Intermediate (K MT) of Key Companies (2015-2020)
Table 13. Global API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Company (2015-2020)
Table 14. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (US$ Million) by Company (2015-2020)
Table 15. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Company (2015-2020)
Table 16. Global API(Active Pharmaceutical Ingredient) Intermediate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in API(Active Pharmaceutical Ingredient) Intermediate as of 2019)
Table 17. Global API(Active Pharmaceutical Ingredient) Intermediate Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers API(Active Pharmaceutical Ingredient) Intermediate Manufacturing Sites and Area Served
Table 19. Manufacturers API(Active Pharmaceutical Ingredient) Intermediate Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key API(Active Pharmaceutical Ingredient) Intermediate Players
Table 22. Global API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Type (2015-2020)
Table 23. Global API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Type (2015-2020)
Table 24. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global API(Active Pharmaceutical Ingredient) Intermediate Price (K MT) by Type (2015-2020)
Table 26. Global API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Type (2021-2026)
Table 27. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Type (2021-2026)
Table 29. Global API(Active Pharmaceutical Ingredient) Intermediate Price (K MT) by Type (2021-2026)
Table 30. Global API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Application (2015-2020)
Table 31. Global API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Application (2015-2020)
Table 32. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global API(Active Pharmaceutical Ingredient) Intermediate Price (K MT) by Application (2015-2020)
Table 34. Global API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Application (2021-2026)
Table 35. Global API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Application (2021-2026)
Table 36. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Application (2021-2026)
Table 38. Global API(Active Pharmaceutical Ingredient) Intermediate Price (K MT) by Application (2021-2026)
Table 39. United States API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Company (2015-2020)
Table 40. United States API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Company (2015-2020)
Table 41. United States API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Type (2015-2020)
Table 42. United States API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type (2015-2020)
Table 43. United States API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Application (2015-2020)
Table 44. United States API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application (2015-2020)
Table 45. Europe API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Company (2015-2020)
Table 46. Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Company (2015-2020)
Table 47. Europe API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Type (2015-2020)
Table 48. Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type (2015-2020)
Table 49. Europe API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Application (2015-2020)
Table 50. Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type (2015-2020)
Table 51. China API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Company (2015-2020)
Table 52. China API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Company (2015-2020)
Table 53. China API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Type (2015-2020)
Table 54. China API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type (2015-2020)
Table 55. China API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Application (2015-2020)
Table 56. China API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application (2015-2020)
Table 57. Japan API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Company (2015-2020)
Table 58. Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Company (2015-2020)
Table 59. Japan API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Type (2015-2020)
Table 60. Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type (2015-2020)
Table 61. Japan API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Application (2015-2020)
Table 62. Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application (2015-2020)
Table 69. India API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Company (2015-2020)
Table 70. India API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Company (2015-2020)
Table 71. India API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Type (2015-2020)
Table 72. India API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type (2015-2020)
Table 73. India API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Application (2015-2020)
Table 74. India API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application (2015-2020)
Table 75. Jigs Chemical Corporation Information
Table 76. Jigs Chemical Description and Business Overview
Table 77. Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Product
Table 79. Jigs Chemical Recent Development
Table 80. Sanofi Winthrop Industrie S.A. Corporation Information
Table 81. Sanofi Winthrop Industrie S.A. Description and Business Overview
Table 82. Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Product
Table 84. Sanofi Winthrop Industrie S.A. Recent Development
Table 85. Shandong Jiulong Fine Chemical Co., Ltd. Corporation Information
Table 86. Shandong Jiulong Fine Chemical Co., Ltd. Description and Business Overview
Table 87. Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Product
Table 89. Shandong Jiulong Fine Chemical Co., Ltd. Recent Development
Table 90. Hipharma Limited Corporation Information
Table 91. Hipharma Limited Description and Business Overview
Table 92. Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Product
Table 94. Hipharma Limited Recent Development
Table 95. AMPAC Fine Chemicals Corporation Information
Table 96. AMPAC Fine Chemicals Description and Business Overview
Table 97. AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Product
Table 99. AMPAC Fine Chemicals Recent Development
Table 100. BASF Corporation Information
Table 101. BASF Description and Business Overview
Table 102. BASF API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. BASF API(Active Pharmaceutical Ingredient) Intermediate Product
Table 104. BASF Recent Development
Table 105. Cambrex Corporation Corporation Information
Table 106. Cambrex Corporation Description and Business Overview
Table 107. Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Product
Table 109. Cambrex Corporation Recent Development
Table 110. A R Life Sciences Pvt. Ltd. Corporation Information
Table 111. A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. A R Life Sciences Pvt. Ltd. Description and Business Overview
Table 113. A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Product
Table 114. A R Life Sciences Pvt. Ltd. Recent Development
Table 115. Dragon Hwa ChemPharm. Co., Ltd. Corporation Information
Table 116. Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Dragon Hwa ChemPharm. Co., Ltd. Description and Business Overview
Table 118. Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Product
Table 119. Dragon Hwa ChemPharm. Co., Ltd. Recent Development
Table 120. Ami Life Sciences Pvt. Ltd. Corporation Information
Table 121. Ami Life Sciences Pvt. Ltd. Description and Business Overview
Table 122. Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Product
Table 124. Ami Life Sciences Pvt. Ltd. Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. API(Active Pharmaceutical Ingredient) Intermediate Distributors List
Table 128. API(Active Pharmaceutical Ingredient) Intermediate Customers List
Table 129. API(Active Pharmaceutical Ingredient) Intermediate Market Key Trends
Table 130. API(Active Pharmaceutical Ingredient) Intermediate Key Opportunities and Drivers
Table 131. API(Active Pharmaceutical Ingredient) Intermediate Market Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. API(Active Pharmaceutical Ingredient) Intermediate Product Picture
Figure 2. Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global API(Active Pharmaceutical Ingredient) Intermediate Market Share by Application in 2020 & 2026
Figure 6. Oncology Examples
Figure 7. Diabetes Examples
Figure 8. Endocrinology Examples
Figure 9. Cardiovascular Disease Examples
Figure 10. CNS & Neurological Disorders Examples
Figure 11. Global API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) Growth Rate (2015-2026)
Figure 12. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global API(Active Pharmaceutical Ingredient) Intermediate Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 14. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) Growth Rate (2015-2026)
Figure 18. Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe API(Active Pharmaceutical Ingredient) Intermediate Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China API(Active Pharmaceutical Ingredient) Intermediate Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan API(Active Pharmaceutical Ingredient) Intermediate Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India API(Active Pharmaceutical Ingredient) Intermediate Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest API(Active Pharmaceutical Ingredient) Intermediate Players Market Share by Revenue in API(Active Pharmaceutical Ingredient) Intermediate 2015 & 2019
Figure 29. API(Active Pharmaceutical Ingredient) Intermediate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Type (2015-2020)
Figure 31. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Application (2015-2020)
Figure 33. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type in 2019
Figure 35. United States API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type in 2019
Figure 36. Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Company in 2019
Figure 37. Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type in 2019
Figure 38. Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application in 2019
Figure 39. China API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Company in 2019
Figure 40. China API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type in 2019
Figure 41. China API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application in 2019
Figure 42. Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Company in 2019
Figure 43. Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type in 2019
Figure 44. Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application in 2019
Figure 45. Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Company in 2019
Figure 46. Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type in 2019
Figure 47. Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application in 2019
Figure 48. India API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Company in 2019
Figure 49. India API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type in 2019
Figure 50. India API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application in 2019
Figure 51. Key Raw Materials Price Trend
Figure 52. Manufacturing Cost Structure of API(Active Pharmaceutical Ingredient) Intermediate
Figure 53. Manufacturing Process Analysis of API(Active Pharmaceutical Ingredient) Intermediate
Figure 54. API(Active Pharmaceutical Ingredient) Intermediate Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Porter's Five Forces Analysis
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
低分子医薬品有効成分の世界市場レポート2020 Market Analysis and Insights: Global Small Molecule Active Pharmaceutical Ingredient Market The global Small Molecule Active Pharmaceutical Ingredient market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Small Molecule Activ…- 化粧品有効成分の世界市場レポート2020 Cosmetics are not allowed to have drug effects. So in cosmetics, the term “active ingredient” is a marketing term for an ingredient that people believe has some effect but is not legally allowed to. For example, some marketers say Vitamin C is an active ingredient for skin lightening. The major prod…
- 医薬品有効成分（API）の世界市場レポート2020 An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain m…
- チョコレート成分の世界市場レポート2020 Industrial Chocolate can be used as a flavoring ingredient in processed foods and catering industry. Market Analysis and Insights: Global Chocolate Ingredient Market The global Chocolate Ingredient market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX…
- テクスチャー食品成分の世界市場レポート2020 Market Analysis and Insights: Global Textural Food Ingredient Market The global Textural Food Ingredient market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Textural Food Ingredient Scope and Market Size The global Textural…